Skip to main content
Clinical Trials/NCT06239961
NCT06239961
Completed
Not Applicable

Multi-Component Behavioral Activation, Nutrition, and Activity Intervention for Persons Aging With HIV

University of Maryland, Baltimore1 site in 1 country7 target enrollmentSeptember 23, 2024
ConditionsHIV

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
HIV
Sponsor
University of Maryland, Baltimore
Enrollment
7
Locations
1
Primary Endpoint
Loneliness
Status
Completed
Last Updated
10 months ago

Overview

Brief Summary

This study will explore if a behavioral intervention program to assist people aged 50 and older with HIV is practical. The program includes a coach who talks with participants, encouraging them to be more active, reduce loneliness, and eat healthier.

Detailed Description

This study aims to see if a 12-week program called Behavioral Activation (BA) can help people aged 50 and above with HIV by reducing loneliness and boosting social engagement. The program includes physical activity and nutrition guidance and is led by remote coaches. Investigators will recruit participants from the University of Maryland THRIVE program and other HIV centers in Baltimore. Investigators will test the program with 10 people aged 50 and above with HIV to see if it works. If it proves to be helpful and accepted, investigators might move on to a larger study to evaluate it more thoroughly.

Registry
clinicaltrials.gov
Start Date
September 23, 2024
End Date
June 19, 2025
Last Updated
10 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ann Gruber-Baldini

Principal Investigator

University of Maryland, Baltimore

Eligibility Criteria

Inclusion Criteria

  • 50 years of age or older
  • HIV positive diagnosis
  • Montreal Cognitive Assessment score \> 13
  • Report minimal level of loneliness, isolation, and/or depression (PHQ9 \> 5)
  • Able to consent
  • Ability to read or speak English
  • Attend the UM THRIVE Center or another HIV center in Baltimore

Exclusion Criteria

  • No severe cognitive impairment

Outcomes

Primary Outcomes

Loneliness

Time Frame: Baseline and Week 16

Participants will complete the University of California, Los Angeles (UCLA) Loneliness Questionnaire (Version 3) at baseline and at the Week 16 follow up visit. This is a 20-item scale designed to measure one's subjective feelings of loneliness. Participants rate each item on a scale where 1 = Never, 2 = rarely, 3 = sometimes and 4 = Often. Total scores of 20 - 40 are considered low to moderate, 40 - 60 are considered moderate to high, and score above 60 are considered high in terms of loneliness.

Total Sleep Time (TST) with Actigraphy

Time Frame: Baseline and Week 16

TST will be measured by a wearable sensor, from baseline to the final week of the intervention.

Nutritional Intake

Time Frame: Baseline

Participants will complete the 18-item Mini Nutritional Assessment (MNA®) at the baseline visit. The MNA® is a screening tool to help identify elderly persons who are malnourished or at risk of malnutrition. A score of 12 or greater indicates the person is well nourished and needs no further intervention. A score of 8-11 indicates the person is at risk of malnutrition. A score of 7 or less indicates the person is malnourished.

Physical Activity (actigraphy) steps

Time Frame: Baseline and Week 16

Participants will be given a wearable sensor device to track movements. Physical activity will be assessed using number of daily steps walked measured by the wearable sensor.

Depression

Time Frame: Baseline and Week 16

Participants will complete the Patient Health Questionnaire - 9 (PHQ-9) at baseline and at the Week 16 follow up visit. The nine items of the PHQ-9 are based directly on the nine diagnostic criteria for major depressive disorder in the DSM-IV. Where total scores of 5 to 9 = mild, 10 to 14 = moderate, 15 to 19 = moderately severe, and 20 = severe depression.

Sleep Efficiency (SE) with Actigraphy

Time Frame: Baseline and Week 16

SE will be measured by a wearable sensor, from baseline to the final week of the intervention.

Sleep Onset Latency (SOL) with Actigraphy

Time Frame: Baseline and Week 16

SOL will be measured by a wearable sensor, from baseline to the final week of the intervention.

Social Isolation

Time Frame: Baseline and Week 16

Participants will complete the Patient-Reported Outcomes Measurement Information System (PROMIS) Social Isolation Scale at Baseline and at the Week 16 follow up visit, to measure social isolation. Total scores of 0.5 - 1.0 SD (standard deviation) worse than the mean = mild symptoms/impairment, scores of 1.0 - 2.0 SD worse than the mean = moderate symptoms/impairment, and scores 2.0 SD or more worse than the mean = severe symptoms/impairment.

Physical Activity (actigraphy) sedentary time

Time Frame: Baseline and Week 16

Participants will be given a wearable sensor device to track movements. Physical inactivity will be assessed using minutes of sedentary time measured by a wearable sensor.

Secondary Outcomes

  • Race(Baseline)
  • Education(Baseline)
  • CD4 count(Baseline)
  • Age(Baseline)
  • Generalized Anxiety Disorder 7(Baseline and Week 16)
  • Engagement in activities(Baseline and Week 16)
  • Reece 9-item HIV-related Stigma Scale(Baseline and Week 16)
  • Sexual preference(Baseline)
  • Aspirin usage(Baseline)
  • ASCVD Risk Score(Baseline)
  • Gender at birth(Baseline)
  • Bone Mineral Density (BMD)(Baseline)
  • Late Life Function and Disability Instrument(Baseline and Week 16)
  • Gender identity now(Baseline)
  • Smoking Status(Baseline)
  • Blood pressure(Baseline)
  • Lipids (Total cholesterol, Low-density lipoprotein (LDL), High-density lipoprotein (HDL), Triglycerides (TG))(Baseline)
  • Statin usage(Baseline)
  • HIV viral load(Baseline)
  • Diabetes status(Baseline)
  • Urine Albumin(Baseline)
  • Glomerular Filtration Rate(Baseline)

Study Sites (1)

Loading locations...

Similar Trials